A Randomized Controlled Trial Comparing Nitazoxanide Plus Lactulose With Lactulose Alone in Treatment of Overt Hepatic Encephalopathy.
Background and Aims: Hepatic encephalopathy (HE) is a reversible spectrum of neuropsychiatric abnormalities associated with liver dysfunction. Lactulose is a nonabsorbable disaccharide presently used to treat HE. Nitazoxanide (NTZ) has a broad-spectrum activity against urease-producing bacteria, so...
| Publicado en: | Journal of Clinical Gastroenterology Vol. 53; no. 3; pp. 226 - 231 |
|---|---|
| Autores principales: | , , , , , , , , , |
| Formato: | research randomized controlled trial Journal Article |
| Publicado: |
Lippincott Williams & Wilkins
Mar2019
|
| Acceso en línea: | Ver este registro en EBSCOhost |